Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
EAGLE PHARMACEUTICALS, INC. (EGRX)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 2.5 | 2.1 | 4.6 | 6.4 | 6.3 | 8.6 | 4.0 | |
| Asset turnover | 1.0 | 0.7 | 0.7 | 0.8 | 0.8 | 1.0 | 1.1 | |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | 63.8% | 7.8% | 26.1% | 21.3% | 68.0% | 101.7% | 245.5% | |
| ROIC (including intangibles) | 18.9% | 4.7% | 13.9% | 12.2% | 33.4% | 45.3% | 65.1% | 16.8% |
| ROE | 20.1% | 3.0% | 9.4% | 7.9% | 27.1% | 29.9% | 46.2% | 2.8% |
| ROA | 11.6% | 2.1% | 6.9% | 5.6% | 18.3% | 19.9% | 37.4% | 2.1% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 83.5 | 87.6 | 99.3 | 89.4 | 113.8 | 83.0 | 81.3 | 144.8 |
| Days payables outstanding | 81.1 | 190.2 | 68.0 | 41.6 | 85.4 | 129.7 | 150.1 | 181.4 |
| Days inventory outstanding | 204.1 | 253.6 | 87.6 | 50.0 | 71.5 | 55.4 | 27.9 | 707.3 |
| Cash conversion cycle | 206.5 | 151.0 | 118.9 | 97.9 | 99.9 | 8.7 | -40.9 | 670.7 |
|